Inspiratory muscle training in pulmonary rehabilitation program in COPD patients  by Magadle, Rasmi et al.
ARTICLE IN PRESS
Respiratory Medicine (2007) 101, 1500–15050954-6111/$ - see fr
doi:10.1016/j.rmed.
Corresponding au
fax: +11 972 4 63045
E-mail address: wInspiratory muscle training in pulmonary
rehabilitation program in COPD patients
Rasmi Magadlea, Alison K. McConnellb, Marinella Beckermana,
Paltiel Weinera,aDepartment of Medicine A, Hillel Yaffe Medical Center, Hadera 38100, Israel
bCentre for Sports Medicine & Human Performance, Uxbridge, Middlesex, UK
Received 23 August 2006; accepted 9 January 2007
Available online 27 February 2007KEYWORDS
Inspiratory muscle
training;
Pulmonary
rehabilitation;
COPDont matter & 2007
2007.01.010
thor. Tel.: +11 972
24.
einer@hillel-yaffeSummary
Most pulmonary rehabilitation (PR) programs do not currently incorporate IMT in their PR
programs for COPD patients.
The aim of the present study was to assess the influence of adding IMT to the patients
already involved in a rehabilitation program.
Thirty-four patients with significant COPD were recruited for the study. All patients
participated in a general exercise reconditioning (GER) program for 12 weeks. The patients
were then randomized to receive IMT or sham IMT, in addition to GER for the next
6 months.
Following three months of GER training there was a significant increase in the 6-min walk
test (6MWT) (from mean7SEM 254738 to 322742m, po0.01), and small but non-
significant decreases in the perception of dyspnea (POD), and in the St. George Respiratory
Questionnaire score (SGRQ). Following the addition of IMT to the GER program there was a
significant increase in the PImax in the GER+IMT group (from 6674.7 to 7874.5 cm H2O,
po0.01). This was accompanied by a significant improvement in the POD and a further
significant improvement in the SGRQ score.
IMT provides additional benefits to patients undergoing PR program and is worthwhile even
in patients who have already undergone a GER program.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
4 6304527;
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A recent guideline by the American Thoracic Society defined
pulmonary rehabilitation (PR) as ‘‘a multidisciplinary pro-
gram of care for patients with chronic respiratory impair-
ment that is individually tailored and designed to optimize
physical and social performance and autonomy’’.1
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Inspiratory muscle training 1501PR is a therapy that, without affecting lung function,
impacts positively upon some of the other sensory and
metabolic consequences of the disease.
For example, PR decreases the perception of dyspnea
(POD),2,3 enhances exercise capacity,4,5 reduces healthcare
resource utilization,6,7 and improves health status.8 Reduc-
tion of lactic acidosis, reduction in minute ventilation and
heart rate for a given work rate and enhanced activity of
mitochondrial enzymes and improved capillary density in
the trained muscles, are among the underlying physiological
changes that contribute to these improvements.9
Although not universally accepted many studies have
shown that patients with significant COPD have inspiratory
muscle weakness that may contribute to dyspnea and to
exercise intolerance.10,11 Inspiratory muscle dysfunction
appears to be the result of geometric changes of the thorax
and diaphragm, due to hyperinflation, as well as systemic
factors and potential structural changes within the mus-
cles.12,13
Recent evidence suggests that there is a fundamental
deficit of diaphragm fibre contractile force in patients with
COPD.14 Thus, there would appear to be a sound theoretical
rational for inspiratory muscle training, in order to reverse
the functional deficit that is present in these patients.
In 1997, the joint ACCP/AACVPR committee15 concluded
that there was sufficient evidence to recommend IMTas part
of a program of PR. They concluded that in studies where
the stimulus or load placed on the inspiratory muscles during
training was sufficient to augment inspiratory muscle
strength, there was an associated increase in exercise
capacity and decrease in dyspnea. Similarly, the findings of
the meta-analysis of IMT in patients with COPD performed by
Lotters and associates16 suggest that IMT reduces exertional
dyspnea in patients with COPD. In addition, when dyspnea is
attenuated, an associated effect of IMT is improved
functional exercise capacity. In studies that used appro-
priate selection criteria and where post-IMT changes in
exercise tolerance were assessed, most have found a
significant improvement.17–21 In the most recent meta-
analysis, that was also conducted in order to determine the
effect of IMT in adults with COPD, it was concluded that
controlled IMT significantly improves inspiratory muscle
strength and endurance, decreases dyspnea and improves
some outcomes of exercise capacity.22
Despite the ample evidence that IMT generates improve-
ments in inspiratory muscle function that yield functional
benefits for patients with COPD, IMT does not appear to be
incorporated routinely into PR programs for COPD pa-
tients.23
The present study was designed in order to evaluate the
effect of adding IMT to the training of COPD patients already
involved in a long term PR program. We assessed lung
function, inspiratory muscle strength, POD, exercise perfor-
mance, and quality of life, in patients with significant COPD.Patients and methods
Subjects
Thirty-four consecutive patients, 26 men and eight women
were recruited. They had spirometric evidence of significantchronic air-flow limitation (FEV1o50% predicted, FEV1/
FVCo70% predicted) and were diagnosed as having COPD
according to American Thoracic Society criteria.24 All
patients were new to a PR program, and none took any
additional regular exercise or nutritional supplements. All
were on regular long-acting bronchodilators, and inhaled
corticosteroid therapy. Patients were observed during a
four-week run-in period, when their regular treatment was
maintained, to verify stability in their clinical and functional
status.
Patients with cardiac disease, poor compliance, or
requirement of supplemental oxygen, were excluded from
the study.
Study design
The study had a double-blind, randomized controlled
design. The PR program was divided into the two phases:
pre- and post-randomization. In the pre-randomization
phase all patients participated in a general exercise
reconditioning (GER) program that included lower extremity
endurance exercise (walking or cycling), upper extremity
exercise and strength training with free weights. This phase
included 36 sessions of 112 h duration (three times a week for
12 weeks).
After the first 12 weeks, the patients were randomized
into two groups, for the second phase of the study (post-
randomization), using a random numbers table. Half of the
group was assigned to receive GER plus IMT (training group)
using a pressure threshold device (POWERbreathes, Gaiam
Ltd., Southam, UK) and a protocol similar to that described
previously.20,25 The other half of the group undertook GER
plus IMT at a load known not to yield improvements in
inspiratory muscle function (sham training control
group).20,25 During this phase, GER took place for 1 h three
times a week, for six months. Patients were not aware which
group they had been allocated to.
Several practice tests were performed by all patients
prior to baseline data collection in order to minimize
possible learning effects. All data were collected by
the same investigator, who was blinded to the training
group.
The training was performed in a community-based
rehabilitation center under the supervision of a respiratory
therapist.
The study protocol was approved by the institutional
ethics committee and informed consent was obtained from
all the patients.
Outcome measures
All assessments were performed before and three, six, and
nine months after starting the PR intervention.
Spirometry: The forced vital capacity (FVC) and the
forced expiratory volume in one second (FEV1) were
measured three times on a computerized spirometer
(Compact, Vitalograph, Buckingham, England) and the best
trial is reported.
Six-minute walk test (6MWT): The distance the patient
was able to walk in 6min was determined in a measured
corridor as described for the 12-min walk test by McGavin
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Table 1 Characteristics of patients with COPDa.
IMT Control
ðn ¼ 16Þ ðn ¼ 15Þ
Age (yr) 65.273.4 66.173.2
Sex (M/F) 11/5 12/3
Weight (kg) 78.173.6 79.773.4
Height (m) 1.6873.2 1.7073.4
FVC (L) 2.4171.2 2.4371.0
% Predicted 6674.6 6874.4
FEV1 (L) 1.2870.4 1.2970.4
% Predicted 4572.4 4672.7
6MW (m) 244731 253739
PImax (cm) H2O 6674.7 6774.6
Current smokers 3 2
Ex-smokers 13 13
aValues are expressed as mean7SEM.
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R. Magadle et al.1502and coworkers.26 The patients were instructed to walk at
their fastest pace and cover the longest possible distance
over 6min under the supervision of a physiotherapist. The
test was performed twice and the best result is reported.
Inspiratory muscle strength: Inspiratory muscle strength
was assessed by measuring the maximal inspiratory mouth
pressure (PImax) at residual volume (RV), as previously
described by Black and Hyatt.27 Mouth pressures were
measured with a vacuumed 1002 mouthpiece (Ventura,
CA), that has a small air leak to prevent pressure generation
by glottis closure, connected to a pressure transducer (1050
BP transducer, Biopac System) and recorded on a strip chart
recorder. Some training sessions were performed before the
measurements, until reproducibility was obtained. The
value obtained from the best of at least three efforts
was used.
Dyspnea: The POD was measured while the subject
breathed through a device similar to that described by
Nickerson and Keens,28 and using a protocol described
previously.25 The subjects breathed against progressive
resistance, at 1min intervals, in order to achieve mouth
pressure of 0 (no resistance), 5, 10, 20 and 30 cm H2O. After
breathing for 1min at each inspiratory load, the subjects
rated the sensation of difficulty in breathing (dyspnea) using
a modified Borg CR-10 scale.29 This is a linear scale of
numbers ranking the magnitude of difficulty in breathing,
ranging from 0 (none) to 10 (maximal).
Health-related quality of life: Health-related quality of
life was measured by the St. George’s Respiratory Ques-
tionnaire.3035
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The results are expressed as mean7SEM. Comparisons of
lung function, inspiratory muscle strength, the 6MWT, and
POD, within and between the two groups were carried out
using the two-way ANOVA with repeated measures.Figure 1 FEV1 (% of predicted) of the patients involved in the
PR program before and following the GER period and before
during and following the GER+IMT period.
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Figure 2 Inspiratory muscle strength, as assessed by the PImax
(maximal mouth inspiratory pressure), before and following the
GER period and before during and following the GER+IMT
period, in the study group and in the control group. Already at
the three month period after the addition of IMT there was a
statistically significant difference between the groups.Results
First phase
Three patients dropped out of the first phase of the study.
The remaining 31 patients were randomized for the second
phase of the study. Their characteristics are summarized in
Table 1. There were no significant differences between the
two groups in age, height, weight, mean baseline ABG, FEV1
and FVC, PImax, the 6MWT, and health-related quality of life,
at the beginning of the study.
The attendance rate in the first phase of the study was
68%77% in the training group (GER+IMT) and 70%78% in the
control group (GER+sham IMT).
Following the first three months of GER-only training
there was no statistically significant change in the FEV1, FVC
or PImax in either group (Figs. 1 and 2). However, there was a
significant increase in the 6MWT (from mean7SEM 254738
to 322742m, 26%, po0.01), and a small but non-significant
decrease in the POD (from 22.870.6 to 20.670.5 total Borg
score), and the St. George Respiratory Questionnaire (SGRQ)
score (from 60.172.1 to 56.372.5 total SGRQ score)
(Fig. 3–5).
ARTICLE IN PRESS
100
200
300
400
500
6
M
W
T
 (
m
)
60
Training group
Control group
GER GERG ER+IMT
Months
3 9
Figure 3 The mean7SEM distance walked in 6min, before and
following the GER period and before during and following the
GER+IMT period, in the study group and in the control group.
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Figure 4 The mean7SEM perception of dyspnea (Borg score),
before and following the GER period and before during and
following the GER+IMT period, in the study group and in the
control group. Already at the three month period after the
addition of IMT there was a statistically significant difference
between the groups.
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Figure 5 Changes in health-related quality-of-life scores
determined by the St. George Respiratory Questionnaire, before
and following the GER period and before during and following
the GER+IMT period, in the study group and in the control
group. At the six month period after the addition of IMT there
was a statistically significant difference between the groups.
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Figure 6 The correlation between the increase in the
inspiratory muscle strength and the decrease in the perception
of dyspnea, in the GER+IMT group.
Inspiratory muscle training 1503Second phase
During the second phase of the study four more patients
dropped out of the study (two from the study group and two
from the control group).
Following the addition of IMT to the GER program the FEV1
and the 6MWT remained unchanged, with no difference
between the groups (Fig. 1 and 3).
There was a significant difference in the PImax between
the training group and control groups after three months of
training and this difference was maintained after a further
three months of training (Fig. 2). The difference arose via an
increase in PImax in the training group that did not occur in
the control group.
There was a significant decrease in the POD in the train-
ing group (from 20.270.4 to 14.970.3 total Borg score,
po0.001), but not in the control group (Fig. 4). Thedifference between the two groups was statistically
significant.
There was a close correlation between the individual
increase in the PImax and the decrease in the POD (po0.005)
in the GER+IMT group (Fig. 6).
There was a continuous decrease in the SGRQ score in
both groups. However, the decrease in the score was greater
in the training group and the difference between the groups
became significant at the end of the sixth month of training
(po0.05) (see also Fig. 5).
Discussion
The results of this study are in concordance with previous
studies demonstrating that in patients with significant COPD,
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R. Magadle et al.1504GER yields improvements in exercise tolerance and quality of
life. Further, the data suggest that the addition of IMT to GER
results in an increase in the inspiratory muscle strength that is
accompanied by a decrease in the POD, and in an improved
quality of life. There was no additional improvement in
exercise performance, as was expressed by the 6MWT, when
IMTwas added to GER. There were no changes in lung function
during any phase of the intervention.
In patients with COPD, exercise capacity, health-related
quality of life, and participation in activities of daily living
are often impaired out of proportion to lung function
impairment.31 Comprehensive PR programs are designed to
tackle the systemic consequences of COPD. Since the first
controlled trials on PR in the mid-1970s, PR has been shown
to result in clinically significant improvements in quality of
life, dyspnea during daily activities and exercise capacity.32
According to the World Health Organization’s Global
Initiative for Chronic Obstructive Lung Disease (GOLD)
consensus document on the management of COPD,33 PR
should be considered in all patients with an FEV1 below 80%
of the predicted value. In our study, following the first three
months of PR without IMT, there was a small but non-
significant decrease in the POD and the SGRQ score. We
believe that with a larger group of patients or longer
duration of rehabilitation we could have shown also
statistical significance in these two parameters.
In patients with advanced COPD, dyspnea is reported as a
limiting factor during exercise, and as a common complaint
during daily activities.10,11 Inspiratory muscle weakness would
be expected to increase the intensity of dyspnea for a given
minute ventilation, since greater motor outflow is required for
a given level of pressure generation by the muscles.11
Inspiratory muscle training has been extensively investi-
gated in patients with COPD. The findings of Lotters and
associates’ recent meta-analysis of IMT in patients with COPD16
suggest that IMT reduces exertional dyspnea in these patients.
These authors concluded that ‘‘inspiratory muscle training is
an important addition to a PR program directed at COPD
patients’’. They also concluded that ‘‘IMT significantly in-
creased inspiratory muscle strength and clinically significant
decrease in dyspnea sensation at rest and during exercise was
observed’’. In the most recent systematic review on this
subject22 it is stated that ‘‘IMTwas associated with significant
improvements in some outcomes of inspiratory muscle
strength (PImax) and endurance (inspiratory threshold loading),
exercise capacity (Borg scale for respiratory effort (modified
Borg scale), work rate maximum (Watts), and dyspnea
(Transition Dyspnea Index)’’. The addition of IMT to PR was
also recommended by the joint ACCP/AACVPR committee.15
Some controversy remains regarding the mechanism for
the enhanced inspiratory muscle force output (strength)
following IMT, with some authors arguing that the inspiratory
muscles of patients with COPD are already well adapted to
chronic loading and do not express any adaptation in
response to training. However, significant changes in the
proportions and sizes of external intercostal muscle fibers
have been observed following IMT,34 and these changes were
accompanied by an increase in both the strength and
endurance properties of the inspiratory muscles.
Somewhat surprisingly, the rationale of adding IMT to PR
is still questioned, and there has been some debate about
whether IMT should be part of rehabilitation programs forCOPD patients. This may be because of two fundamental
misconceptions. Firstly, that the diaphragm of patients with
severe COPD is already well trained. However, the endur-
ance adaptations that have been observed are also
associated with a loss of type 2 muscle fibers, which likely
contributes to the loss of inspiratory muscle strength that is
also observed.35 Loss of inspiratory muscle strength has
negative sensory implications for exertional dyspnea,36
since the muscles are required to act at a mechanical
disadvantage due to hyperinflation. Thus, the inspiratory
muscles of patients with COPD are not well trained, they are
merely adapted to the requirement for an increased
pressure generation during resting breathing. A second
misconception is that GER is capable of providing a training
stimulus that will yield improvements in inspiratory muscle
strength, and that additional, specific, IMT is therefore
redundant. Our data do not support this contention.
The absence of an additive influence of GER and IMTupon
6MWT is somewhat surprising in light of the reduction in POD
elicited by IMT in our study, as well as observations on
healthy young adults that have reported amelioration of
dyspnea assessed during exercise after IMT.37,38 An explana-
tion for this observation may reside within the magnitude
and time course of the changes in 6MWT performance that
we observed. The improvement in 6MWT in response to GER
was substantial, some 26% (68m), and was achieved almost
entirely over the first three months of the nine month
intervention. It is possible that the 26% improvement that
we observed represented full extent of the adaptive
potential of these patients. The finding that a further six
months of GER failed to elicit any additional improvements
in 6MWT performance would tend to support this notion.
Thus, IMT may not have led to any additional improvements
in 6MWT because the patients had already achieved their
full potential in response to GER alone.
Quality of life and dyspnea are unarguably the most
important outcomes from a patient perspective. Since both
of these variables showed significantly greater improve-
ments following the addition of IMT to GER, we argue that
this alone justifies the inclusion of IMT in PR programs. In
addition, a recent randomized controlled trial from our
laboratory39 also demonstrated that patients who had
undergone a 12 month program of IMT (without GER) showed
a reduction in the use of healthcare resources. This was
primarily as a result of a decrease in the time spent in
hospital after admission for an exacerbation. The underlying
mechanism for this appeared to be that the patients
undergoing IMT felt more confident about coping with their
dyspnea, and were therefore released from hospital earlier.
These data lend further support to the inclusion of IMT in PR.
Our findings support the addition of IMT to GER as part of a
program of PR. Although the addition of IMT did not yield
further improvements in 6MWT, it did result in significantly
greater improvements in quality of life and POD than GER alone.
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